Axon Transport of TrkA receptors in sympathetic neurons

交感神经元中 TrkA 受体的轴突运输

基本信息

  • 批准号:
    10189732
  • 负责人:
  • 金额:
    $ 3.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Axons of sympathetic neurons extend millimeters to meters to innervate peripheral tissues and organs, which is essential for tissue homeostasis and fundamental physiological processes including cardiac output, body temperature, regulation of blood glucose levels, and immune functions. Target-derived signals, such as the neurotrophin, Nerve Growth Factor (NGF), recruit growing axons by binding to TrkA receptors located on axon terminals, to initiate local and long-range retrograde signaling events to support neuron development, maturation, and synaptic functions. To sustain functional responses to target derived ligand, TrkA receptors must be continually localized to axon terminals. Yet, how TrkA receptors are delivered to axons remains largely undefined. Previously, we reported that TrkA receptors are delivered to sympathetic axons by transcytosis, where newly synthesized receptors are first inserted on soma surfaces, then internalized and anterogradely transported to axons. Furthermore, we identified that TrkA transcytosis is primed by the activity of PTP1B, an ER-resident protein tyrosine phosphatase, in cell bodies. The overall goal of my thesis project and this application is to test the hypothesis that PTP1B phosphatase promotes a gain of TrkA biological function by controlling the long- distance transcytosis of receptors. I will employ imaging, biochemical, and functional analyses in compartmentalized neuron cultures in combination with in vivo analyses of genetically modified mice to accomplish these goals. Specifically, I have generated a new mouse model, TrkAR685A knock-in mice, where a point mutation in TrkA prevents PTP1B binding, which will allow me to test the functional relevance of TrkA- PTP1B interactions on TrkA localization, neuron survival, and axon innervation of target tissues. Through this fellowship application, I will develop a basic understanding of the mechanisms of Trk receptor delivery to axons, and how this contributes to neuronal development. I will also develop the technical, communication, and leadership skills necessary to accomplish my goal of becoming an independent investigator. My training will be facilitated by the rigorous research plan, the expertise and guidance of my mentor and thesis committee, and the outstanding training resources and facilities available through Johns Hopkins University.
项目概要/摘要 交感神经元的轴突延伸数毫米至数米,支配周围组织和器官, 对于组织稳态和基本生理过程(包括心输出量、身体 温度、血糖水平的调节和免疫功能。目标衍生信号,例如 神经营养蛋白、神经生长因子 (NGF) 通过与轴突上的 TrkA 受体结合来募集正在生长的轴突 终端,启动局部和远程逆行信号事件以支持神经元发育、成熟、 和突触功能。为了维持对靶标衍生配体的功能反应,TrkA 受体必须 不断定位于轴突末端。然而,TrkA 受体如何传递到轴突仍然很大程度上取决于 不明确的。 之前,我们报道了 TrkA 受体通过转胞吞作用传递到交感神经轴突,其中新近 合成的受体首先插入体细胞表面,然后内化并顺行转运至 轴突。此外,我们还发现 TrkA 转胞吞作用是由 PTP1B 的活性引发的,PTP1B 是一种 ER 驻留蛋白。 细胞体内的蛋白质酪氨酸磷酸酶。我的论文项目和这个应用程序的总体目标是测试 PTP1B 磷酸酶通过控制长链来促进 TrkA 生物学功能的获得的假设 受体的距离转胞吞作用。我将采用成像、生化和功能分析 区室化神经元培养与转基因小鼠的体内分析相结合 实现这些目标。具体来说,我生成了一个新的小鼠模型,TrkAR685A 敲入小鼠,其中 TrkA 中的点突变阻止了 PTP1B 结合,这将使我能够测试 TrkA 的功能相关性 PTP1B 对 TrkA 定位、神经元存活和靶组织轴突神经支配的相互作用。通过这个 奖学金申请,我将对 Trk 受体传递到轴突的机制有一个基本的了解, 以及这如何有助于神经元发育。我还将开发技术、沟通和 实现我成为独立调查员的目标所必需的领导技能。我的训练将是 得益于严格的研究计划、我的导师和论文委员会的专业知识和指导,以及 约翰·霍普金斯大学提供出色的培训资源和设施。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Blaine Connor其他文献

Blaine Connor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 3.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了